Machine Learning-Based Prediction of 1-Year Survival Using Subjective and Objective Parameters in Patients With
Maria Rosa Salvador Comino1, Paul Youssef2,3, Anna Heinzelmann1
1Department of Palliative Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
JCO Clinical Cancer Informatics
|August 28, 2024
Summary
Objective clinical data more accurately predicts 1-year cancer mortality than subjective patient-reported variables. Machine learning models show objective variables are superior for survival outcome predictions in palliative care settings.
Area of Science:
- Oncology
- Palliative Care
- Machine Learning
Background:
- Palliative care is crucial for cancer patients with limited life expectancy.
- Machine learning (ML) can enhance survival outcome prediction in oncology.
- Identifying patients who benefit most from palliative care is essential.
Purpose of the Study:
- To evaluate the predictive power of objective and subjective self-reported variables for 1-year cancer mortality.
- To explore the importance of variables from electronic health records and patient self-assessments.
- To compare the efficacy of different machine learning models in predicting mortality.
Main Methods:
- Utilized data from 265 advanced cancer patients (April 2020-March 2021).
- Collected objective clinical data and subjective patient-reported outcomes.
- Employed logistic regression, decision trees, and random forests with 20-fold cross-validation.
- Analyzed performance using ROC-AUC and PR-AUC metrics.
Main Results:
- Objective clinical variables demonstrated superior predictive performance (LR: 0.81 ROC-AUC, 0.72 F1 score).
- Subjective patient-reported variables showed lower predictive accuracy (LR: 0.55 ROC-AUC, 0.52 F1 score).
- Machine learning models highlighted the greater importance of objective data.
Conclusions:
- Objective variables are significantly more predictive of 1-year mortality than subjective patient-reported variables.
- Subjective burden, as measured in this study, is not a reliable predictor of cancer patient survival.
- Further research is warranted to refine ML models for mortality prediction using patient-reported data.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Kaplan-Meier Approach
111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Actuarial Approach
68
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Introduction To Survival Analysis
197
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
197


